CJC-1295 (long-acting GHRH analog) was identified in an unknown pharmaceutical preparation through analytical chemistry, highlighting its availability in the unregulated peptide market and anti-doping implications.
Key findingCJC-1295 (long-acting GHRH analog) was identified in an unknown pharmaceutical preparation through analytical chemistry, highlighting its availability
What the researchers found
CJC-1295 (long-acting GHRH analog) was identified in an unknown pharmaceutical preparation through analytical chemistry, highlighting its availability in the unregulated peptide market and anti-doping implications.
Why it matters
Relevant for peptide research.
How the study worked
research study.
What this study cannot tell us
See abstract.
How to read the evidence
emerging evidence.
When this study was published
Published in 2010.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
Common questions
What was studied?
What was found?
Read the original research
Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation.
Drug testing and analysis, 2(11-12), 647-50
Citation
Henninge, John; Pepaj, Milaim; Hullstein, Ingunn; Hemmersbach, Peter. (2010). Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation.. Drug testing and analysis, 2(11-12), 647-50. https://doi.org/10.1002/dta.233